Collagen glycation alters neovascularization in vitro and in vivo

Microvascular Research

Volumn 80, Issue 1, 2010, Pages 3-9

  Francis Sedlak, Megan E ^a,b   Moya, Monica L ^a   Huang, Jung Ju ^c   Lucas, Stephanie A ^a   Chandrasekharan Nivedita, N ^a   Larson, Jeffery C ^a   Cheng, Ming Huei ^c   Brey, Eric M ^a,b  

^a Illinois Institute of Technology   (United States)

^b HINES VA HOSPITAL   (United States)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Collagen; Diabetes; Glycation; Neovascularization

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; COLLAGEN GEL; COLLAGEN TYPE 1; GLUCOSE 6 PHOSPHATE;

AGING; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; AUTOFLUORESCENCE; CELL CULTURE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CROSS LINKING; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; UMBILICAL VEIN; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; ENDOTHELIAL CELLS; GLUCOSE-6-PHOSPHATASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MYOCYTES, SMOOTH MUSCLE; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE; SPHEROIDS, CELLULAR; UMBILICAL CORD;

EID: 77953535753     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2009.12.005     Document Type: Article

References (33)

1. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 2003, 21(1):3-12.
2. Brey E.M., King T.W., et al. A technique for quantitative three-dimensional analysis of microvascular structure. Microvasc. Res. 2002, 63(3):279-294.
3. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46:223-234.
4. Cerami C., Founds H., et al. Tobacco smoke is a source of toxic reactive glycation products. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(25):13915-13920.
5. Cheng M.H., Uriel S., et al. Dermis-derived hydrogels support adipogenesis in vivo. J. Biomed. Mater. Res. A. 2009.
6. Cronin K.J., Messina A., et al. The role of biological extracellular matrix scaffolds in vascularized three-dimensional tissue growth in vivo. J. Biomed. Mater. Res. B. Appl. Biomater. 2007, 82(1):122-128.
7. Francis M.E., Uriel S., et al. Endothelial cell-matrix interactions in neovascularization. Tissue. Eng. Part. B. Rev. 2008, 14(1):19-32.
8. Francis-Sedlak M.E., Uriel S., et al. Characterization of type I collagen gels modified by glycation. Biomaterials 2009, 30(9):1851-1856.
9. Friedman E.A. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes. Care. 1999, 22(Suppl. 2):B65-B71.
10. Korff T., Augustin H.G. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell. Biol. 1998, 143(5):1341-1352.
11. Kuzuya M., Satake S., et al. Inhibition of endothelial cell differentiation on a glycosylated reconstituted basement membrane complex. Exp. Cell. Res. 1996, 226(2):336-345.
12. Kuzuya M., Satake S., et al. Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 1998, 41(5):491-499.
13. Liao H., Zakhaleva J., et al. Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing. Biomaterials 2009, 30(9):1689-1696.
14. LoGerfo F.W., Gibbons G.W. Vascular disease of the lower extremities in diabetes mellitus. Endocrinol. Metab. Clin. North. Am. 1996, 25(2):439-445.
15. Lutgers H.L., Graaff R., et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes. Care. 2006, 29(12):2654-2659.
16. Martin A., Komada M.R., et al. Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 2003, 23(2):117-145.
17. Monnier V.M., Bautista O., et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes 1999, 48(4):870-880.
18. Monnier V.M., Mustata G.T., et al. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on a puzzle nearing resolution. Ann. N. Y. Acad. Sci. 2005, 1043:533-544.
19. Olde Damink L.H.H., Dijkstra P.J., et al. Glutaraldehyde as a crosslinking agent for collagen-based biomaterials. J. Mater. Sci:. Mater. Med. 1995, 6(8):460-472.
20. Reihsner R., Melling M., et al. Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation. Clin. Biomech. (Bristol., Avon). 2000, 15(5):379-386.
21. Reiser K.M. Nonenzymatic glycation of collagen in aging and diabetes. Proc. Soc. Exp. Biol. Med. 1991, 196(1):17-29.
22. Rittie L., Berton A., et al. Decreased contraction of glycated collagen lattices coincides with impaired matrix metalloproteinase production. Biochem. Biophys. Res. Commun. 1999, 264(2):488-492.
23. Rothamel D., Schwarz F., et al. Biodegradation of differently cross-linked collagen membranes: an experimental study in the rat. Clin. Oral. Implants. Res. 2005, 16(3):369-378.
24. Schnider S.L., Kohn R.R. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J. Clin. Invest. 1981, 67(6):1630-1635.
25. Sheetz M.J., King G.L. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. Jama 2002, 288(20):2579-2588.
26. Sheu M.T., Huang J.C., et al. Characterization of collagen gel solutions and collagen matrices for cell culture. Biomaterials 2001, 22(13):1713-1719.
27. Sieminski A.L., Hebbel R.P., et al. The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp. Cell. Res. 2004, 297(2):574-584.
28. Tamarat R., Silvestre J.S., et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(14):8555-8560.
29. Uriel S., Brey E.M., et al. Sustained low levels of fibroblast growth factor-1 promote persistent microvascular network formation. Am. J. Surg. 2006, 192(5):604-609.
30. Uriel S., Huang J.J., et al. The role of adipose protein derived hydrogels in adipogenesis. Biomaterials 2008, 29(27):3712-3719.
31. Verzijl N., DeGroot J., et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J. Biol. Chem. 2000, 275(50):39027-39031.
32. Yamagishi S., Ueda S., et al. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders. Curr. Pharm. Des. 2007, 13(27):2832-2836.
33. Yamamura N., Sudo R., et al. Effects of the mechanical properties of collagen gel on the in vitro formation of microvessel networks by endothelial cells. Tissue. Eng. 2007, 13(7):1443-1453.